NYSE:PEN
Penumbra Inc Stock News
$190.69
-8.28 (-4.16%)
At Close: May 23, 2024
Penumbra, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 4, 2022
04:05pm, Thursday, 07'th Jul 2022
ALAMEDA, Calif. , July 7, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2022 after market clos
Strong Revenue Trends And Better Prospects Make Penumbra Stock A Good Bet
08:15am, Tuesday, 24'th May 2022
We think that Penumbra (NYSE: PEN), a medical devices company focused on interventional therapies, currently is a better pick compared to the Gap stock (NYSE: GPS), a specialty retailer selling casual
Despite Seeing Accelerated 2023 Growth, This Analyst Cut Penumbra's Price Target - Here's Why
04:05pm, Wednesday, 04'th May 2022
Penumbra Inc (NYSE: PEN) reported Q1 sales that beat Street expectations, driven by Vascular upside, and reiterated its 2022 revenue guidance. Wells Fargo lowered the price target to $265 from
Penumbra's (PEN) CEO Adam Elsesser on Q1 2022 Results - Earnings Call Transcript
11:32pm, Tuesday, 03'rd May 2022
Penumbra, Inc. (NYSE:PEN ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief Executive Officer
Penumbra, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 3, 2022
04:05pm, Tuesday, 05'th Apr 2022
ALAMEDA, Calif. , April 5, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2022 after market clos
Penumbra, Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
04:05pm, Monday, 28'th Mar 2022
ALAMEDA, Calif. , March 28, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 21st Annual Needham Virtual Healthcare Conference on
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
04:00pm, Friday, 25'th Mar 2022
Looking for small healthcare companies with huge revenue opportunities? Try these.
Down 16% In A Month, Will Penumbra Stock Rebound?
06:30am, Tuesday, 15'th Mar 2022
The stock price of Penumbra, a medical devices company focused on interventional therapies, has seen a 16% fall in a month, while it was down 10% last week. The company reported mixed Q4 results last
Penumbra Stock: A Medical Device Recovery Play With Strong Growth Potential
06:33pm, Sunday, 06'th Mar 2022 Seeking Alpha
Penumbra A Little Beaten Down Despite Strong Growth Opportunities
09:48pm, Tuesday, 01'st Mar 2022 Seeking AlphaPenumbra A Little Beaten Down Despite Strong Growth Opportunities
04:48pm, Tuesday, 01'st Mar 2022
Penumbra has been posting strong revenue growth numbers, but the Street has not been rewarding the shares.
Penumbra Posts Mixed Bag Q4 Results, Reports Topline Growth Of 22%
02:05pm, Wednesday, 23'rd Feb 2022
Penumbra Inc (NYSE: PEN) posted Q4 FY21 revenue of $204 million, +22.2% Y/Y (up 23% in constant currency), beating the consensus of $194.30 million. Revenue from sales of vascular products grew 30.4
Wall Street Analysts Believe Penumbra (PEN) Could Rally 40%: Here's is How to Trade
11:34am, Wednesday, 23'rd Feb 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 40.2% in Penumbra (PEN). While the effectiveness of this highly sought-after metric is questionable, the positi
Penumbra, Inc. (PEN) CEO Adam Elsesser on Q4 2021 Results - Earnings Call Transcript
02:33am, Wednesday, 23'rd Feb 2022 Seeking AlphaPenumbra, Inc. (PEN) CEO Adam Elsesser on Q4 2021 Results - Earnings Call Transcript
09:33pm, Tuesday, 22'nd Feb 2022
Penumbra, Inc. (PEN) CEO Adam Elsesser on Q4 2021 Results - Earnings Call Transcript
